Comparative Study of Selective α1‐Adrenoceptor Blockade versus Surgery in the Treatment of Prostatic Obstruction
- 26 November 1993
- journal article
- Published by Wiley
- Vol. 72 (5) , 822-825
- https://doi.org/10.1111/j.1464-410x.1993.tb16275.x
Abstract
Summary Alternative treatments for benign prostatic hyperplasia (BPH) are the source of much discussion at present. Pharmacotherapy has been demonstrated to have an increasing role in the management of BPH. This study contrasts the efficacy of the selective alpha, antagonist prazosin as compared with placebo and the subsequent improvements seen following surgical treatment. Whilst selective alpha, blockade has undoubted therapeutic efficacy the improvement in symptom scores and the objective urodynamic measure of the flow rate are not as marked as those seen following surgery.Keywords
This publication has 18 references indexed in Scilit:
- High prevalence of benign prostatic hypertrophy in the communityThe Lancet, 1991
- Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic interventionThe Prostate, 1990
- Benign prostatic hyperplasia: the best treatment.BMJ, 1989
- Characterisation of Human Prostatic Adrenoceptors using Pharmacology Receptor Binding and LocalisationBritish Journal of Urology, 1989
- Mortality and Reoperation after Open and Transurethral Resection of the Prostate for Benign Prostatic HyperplasiaNew England Journal of Medicine, 1989
- The Natural History of Untreated “Prostatism”British Journal of Urology, 1981
- A Critical Evaluation of the Results of Transurethral Resection of the ProstateBritish Journal of Urology, 1978
- A CONTRIBUTION TO THE NEUROPHYSIOLOGY OF THE URINARY BLADDER IN MANBrain, 1931